Used as a key intermediate in the synthesis of peptide-based pharmaceuticals, particularly in the development of protease inhibitors. Its fluorinated structure enhances metabolic stability and membrane permeability in drug candidates. Commonly employed in solid-phase peptide synthesis to introduce trifluoroacetyl-protected functional groups. Also utilized in the preparation of enzyme inhibitors and diagnostic probes due to its ability to modulate biological activity through controlled conformational effects.